Literature DB >> 9699883

The 5alpha-reductase in the central nervous system: expression and modes of control.

R C Melcangi1, A Poletti, I Cavarretta, F Celotti, A Colciago, V Magnaghi, M Motta, P Negri-Cesi, L Martini.   

Abstract

The present paper will summarize two important aspects of the interactions between steroids and the brain, which have recently been studied in the authors' laboratory. In particular the paper will consider data on: (1) the significance of the two isoforms of the 5alpha-R during brain ontogenesis and development, and (2) the cross-talk between glial and neuronal elements, particularly in relation to the metabolism of sex hormones. (1) The data obtained have shown that the 5alpha-R type 1 enzyme is constitutively expressed in the rat CNS at all stages of brain development. Moreover, the expression of the 5alpha-R type 1 is similar in males and in females, and does not appear to be controlled by androgens. The gene expression of the 5alpha-R type 2 is totally different. This isoform appears to be expressed in the rat brain almost exclusively in the late fetal/early post-natal life and is controlled by testosterone. (2) The present data show that two cell lines derived respectively from a rat glioma (C6 cell line) and from a human astrocytoma (1321N1 cell line) are able to convert testosterone and progesterone into their corresponding 5alpha-reduced metabolites dihydrotestosterone and dihydroprogesterone. The possibility that secretory products of normal and tumoral brain cells might be able to influence steroid metabolism occurring in the two glial cell lines previously mentioned has been considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699883     DOI: 10.1016/s0960-0760(98)00030-2

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  30 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

Authors:  M Paola Castelli; Alberto Casti; Angelo Casu; Roberto Frau; Marco Bortolato; Saturnino Spiga; Maria Grazia Ennas
Journal:  Psychoneuroendocrinology       Date:  2012-07-08       Impact factor: 4.905

Review 3.  Neurosteroids: endogenous role in the human brain and therapeutic potentials.

Authors:  Doodipala Samba Reddy
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 4.  A genetic approach to dissect sexually dimorphic behaviors.

Authors:  Scott A Juntti; Jennifer K Coats; Nirao M Shah
Journal:  Horm Behav       Date:  2008-01-05       Impact factor: 3.587

5.  Female mice with deletion of Type One 5α-reductase have reduced reproductive responding during proestrus and after hormone-priming.

Authors:  Carolyn J Koonce; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

6.  5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients.

Authors:  Roberto Carlos Agis-Balboa; Alessandro Guidotti; Graziano Pinna
Journal:  Psychopharmacology (Berl)       Date:  2014-04-30       Impact factor: 4.530

Review 7.  Epigenetic impacts of endocrine disruptors in the brain.

Authors:  Deena M Walker; Andrea C Gore
Journal:  Front Neuroendocrinol       Date:  2016-09-20       Impact factor: 8.606

8.  Localization of brain 5α-reductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity.

Authors:  Charles E Roselli; Timothy J Finn; Sean M Ronnekleiv-Kelly; Michelle A Tanchuck; Katherine R Kaufman; Deborah A Finn
Journal:  Alcohol       Date:  2011-09-14       Impact factor: 2.405

9.  Steroid 5α-reductase in adult rat brain after neonatal dihydrotestosterone administration.

Authors:  P Sánchez; J M Torres; B Castro; R G Del Moral; J de Dios Luna; E Ortega
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

10.  Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Authors:  Doodipala Samba Reddy; G Ramanathan
Journal:  Epilepsy Behav       Date:  2012-07-24       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.